ArticleCase reports in ophthalmology
Short-Term Outcomes of PreserFlo for Secondary Glaucoma after Combined Descemet Stripping Automated Endothelial Keratoplasty and Artificial Iris-Intraocular Lens Implantation: A Case Report.
Article in Case reports in ophthalmology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Secondary glaucoma following combined corneal transplantation and artificial iris-intraocular lens (IOL) complex implantation represents a significant therapeutic challenge. Reports of surgical management in such complex eyes remain limited. We report a case of successful PreserFlo MicroShunt implantation for the management of secondary glaucoma following combined Descemet stripping automated endothelial keratoplasty (DSAEK) and Reper artificial iris-IOL complex implantation. Case Presentation: A 54-year-old woman with a history of right eye corneal perforation resulting in aphakia underwent combined DSAEK and Reper artificial iris-IOL complex implantation (Reper-NN LTD, Nizhny Novgorod, Russia). Six months after surgery, she developed secondary glaucoma with intraocular pressure (IOP) elevation to 30 mm Hg despite maximal tolerated medical therapy, accompanied by optic disc cupping, retinal nerve fiber layer thinning, and corresponding visual field defects. PreserFlo MicroShunt implantation was performed. Postoperatively, IOP decreased to 6 mm Hg with a well-functioning filtering bleb, and the corneal graft remained clear throughout the 3-month follow-up. Conclusion: To our knowledge, this is the first report describing PreserFlo MicroShunt implantation for secondary glaucoma following combined Reper artificial iris-IOL implantation and endothelial keratoplasty. This case highlights the potential role of PreserFlo as a surgical option for IOP control in highly complex anterior segment eyes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.